Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study ; volume:13 ; number:5 ; day:10 ; month:7 ; year:2024 ; pages:1203-1218 ; date:10.2024
Pain and therapy ; 13, Heft 5 (10.7.2024), 1203-1218, 10.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
True, David
Mullin, Kathleen
Croop, Robert
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40122-024-00626-1
- URN
-
urn:nbn:de:101:1-2411262125473.429639554223
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- True, David
- Mullin, Kathleen
- Croop, Robert
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Galcanezumab in patients with episodic migraine: results from the open-label period of the phase 3 PERSIST study
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Galcanezumab in patients with episodic migraine: results from the open-label period of the phase 3 PERSIST study
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Galcanezumab in patients with episodic migraine: results from the open-label period of the phase 3 PERSIST study
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study